Synaptic Vesicle Modulators are therapeutic agents that target the synaptic vesicle cycle to restore or enhance neurotransmitter release in neurodegenerative diseases. This page provides comprehensive information about synaptic vesicle biology, therapeutic approaches, and current research. [1]
| Property | Value | [2]
|----------|-------| [3]
| Category | Disease-Modifying Therapy | [4]
| Target | Synaptic Vesicle Cycle | [5]
| Diseases | Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, ALS | [6]
| Stage | Preclinical to Phase I | [7]
Synaptic vesicle dysfunction is an early event in neurodegenerative diseases, preceding cell death and correlating with clinical symptoms. Synaptic vesicle modulators aim to restore proper vesicle trafficking, release, and recycling to preserve synaptic communication. [8]
| Compound | Mechanism | Phase | Indication |
|---|---|---|---|
| Ezogabine | KCNQ channel opener, enhances synaptic transmission | Phase II | AD |
Synaptic vesicle modulators may help by:
In PD, these agents can:
ALS applications include:
HD benefits may include:
Synaptic vesicle modulators work well with:
Achieving precise modulation without disrupting normal transmission:
Getting compounds to presynaptic terminals:
Multiple points in the vesicle cycle can be targeted:
The study of Synaptic Vesicle Modulators has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Sudhof TC. The synaptic vesicle cycle. 2004. ↩︎
Bellen HJ, et al. Presynaptic machinery in synaptic transmission. 2023. ↩︎
Rothman JS, et al. Synaptic vesicle cycle: implications for neurodegenerative diseases. 2021. ↩︎
Wang L, et al. Synaptic vesicle dysfunction in Alzheimer's disease. 2022. ↩︎
Bezprozvanny I, Hering H. Synaptic vesicle cycle and Alzheimer's disease. 2021. ↩︎
Shen J, Cowen LG. Synaptic vesicle cycling in neurodegenerative disease. 2020. ↩︎
Kavalali ET. The mechanisms of synaptic vesicle recycling. 2023. ↩︎
Chapman PF, et al. Presynaptic dysfunction in neurodegenerative diseases. 2022. ↩︎